Suggestions for a PMF Patient on Ruxolitinib Who Has Refractory Anemia, but Only Modest Spleen/ Symptom Response?
Dr. Srdan Verstovsek, MD Anderson Cancer Center, answers the following question: What would you suggest for a PMF patient on ruxolitinib who has refractory anemia, but only modest spleen/symptom response? [eg, Increase dosage? Change therapy- to what? Allo-SCT? Put on clinical trial?]